LeMaitre Vascular Long-Term Investments 2010-2024 | LMAT
LeMaitre Vascular long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
| LeMaitre Vascular Annual Long-Term Investments (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $ |
| 2014 | $ |
| 2013 | $ |
| 2012 | $ |
| 2011 | $ |
| 2010 | $ |
| 2009 | $ |
| LeMaitre Vascular Quarterly Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | |
| 2010-09-30 | |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-12-31 | |
| 2009-09-30 | |
| 2009-06-30 | |
| 2009-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.165B | $0.193B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.059B | 26.03 |
| Stryker (SYK) | United States | $139.868B | 31.52 |
| Boston Scientific (BSX) | United States | $124.863B | 35.90 |
| Medtronic (MDT) | Ireland | $114.537B | 17.04 |
| EssilorLuxottica (ESLOY) | France | $110.799B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.365B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.180B | 28.71 |
| GE HealthCare Technologies (GEHC) | United States | $39.743B | 20.61 |
| ResMed (RMD) | United States | $35.761B | 29.39 |
| Terumo (TRUMY) | Japan | $28.532B | 40.29 |
| Koninklijke Philips (PHG) | Netherlands | $25.454B | 19.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.582B | 13.74 |
| Baxter (BAX) | United States | $18.264B | 12.39 |
| Insulet (PODD) | United States | $16.648B | 70.04 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.052B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.282B | 35.10 |
| BellRing Brands (BRBR) | United States | $8.726B | 36.90 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $8.016B | 19.24 |
| ICU Medical (ICUI) | United States | $4.201B | 40.09 |
| TG Therapeutics (TGTX) | United States | $3.771B | 0.00 |
| Haemonetics (HAE) | United States | $3.763B | 18.61 |
| Envista Holdings (NVST) | United States | $3.662B | 27.28 |
| Prestige Consumer Healthcare (PBH) | United States | $3.657B | 18.22 |
| Perrigo (PRGO) | Ireland | $3.466B | 10.95 |
| Neogen (NEOG) | United States | $3.127B | 36.08 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.988B | 18.00 |
| QuidelOrtho (QDEL) | United States | $2.628B | 16.56 |
| Agios Pharmaceuticals (AGIO) | United States | $2.557B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.260B | 38.14 |
| Curaleaf Holdings (CURLF) | Canada | $2.023B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.960B | 0.00 |
| Warby Parker (WRBY) | United States | $1.769B | 0.00 |
| AtriCure (ATRC) | United States | $1.641B | 0.00 |
| InMode (INMD) | Israel | $1.460B | 8.78 |
| AdaptHealth (AHCO) | United States | $1.365B | 9.85 |
| Verano Holdings (VRNOF) | United States | $1.231B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.179B | 0.00 |
| Evolus (EOLS) | United States | $1.036B | 0.00 |
| Owens & Minor (OMI) | United States | $0.925B | 7.23 |
| National Vision Holdings (EYE) | United States | $0.915B | 29.08 |
| Phibro Animal Health (PAHC) | United States | $0.906B | 18.80 |
| CeriBell (CBLL) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.844B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.542B | 16.36 |
| Surmodics (SRDX) | United States | $0.536B | 113.85 |
| Quanterix (QTRX) | United States | $0.532B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.515B | 0.00 |
| Valneva SE (VALN) | France | $0.475B | 0.00 |
| ZimVie (ZIMV) | United States | $0.398B | 33.56 |
| Viemed Healthcare (VMD) | United States | $0.331B | 35.54 |
| Aurora Cannabis (ACB) | Canada | $0.328B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.315B | 8.12 |
| TerrAscend (TSNDF) | Canada | $0.309B | 0.00 |
| Jin Medical (ZJYL) | China | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| Cerus (CERS) | United States | $0.290B | 0.00 |
| Biote (BTMD) | United States | $0.280B | 12.93 |
| Ayr Wellness (AYRWF) | United States | $0.279B | 0.00 |
| Zynex (ZYXI) | United States | $0.255B | 53.33 |
| Omeros (OMER) | United States | $0.246B | 0.00 |
| High Tide (HITI) | Canada | $0.234B | 97.00 |
| MacroGenics (MGNX) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 15.14 |
| Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
| Brainsway (BWAY) | Israel | $0.172B | 206.40 |
| FitLife Brands (FTLF) | United States | $0.145B | 19.54 |
| Rockwell Medical (RMTI) | United States | $0.121B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.117B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| Veru (VERU) | United States | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 23.90 |
| Fonar (FONR) | United States | $0.092B | 9.51 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.082B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.079B | 0.00 |
| InterCure (INCR) | Israel | $0.079B | 0.00 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.064B | 1.63 |
| MariMed (MRMD) | United States | $0.062B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.045B | 0.00 |
| Exagen (XGN) | United States | $0.043B | 0.00 |
| Apyx Medical (APYX) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Nephros (NEPH) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 17.87 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |